Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond total BDNF: The proBDNF/mBDNF balance in substance use disorders.

Neurobiology of disease·2026
Same author

Unraveling the vascular-cognitive axis in offspring exposed to preeclampsia and eclampsia.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Development and validation of matrix-validated LC-MS/MS method for simultaneous quantification of 21 neonicotinoids and their metabolites in human urine.

Environmental science and pollution research international·2026
Same author

Renovating the Barnes maze for mouse models of dementia with STARR FIELD: A 4-day protocol for learning rate, retention, and cognitive flexibility.

Methods (San Diego, Calif.)·2026
Same author

Maternal Smoking Status and Residual Risk: Current and Former Smoking Amplify Congenital Heart Disease Incidence and Severity in Offspring.

Research square·2026
Same author

Higher carotid artery backward pressure and load-dependent stiffness among women with a history of preeclampsia: association with cognitive functions.

Journal of applied physiology (Bethesda, Md. : 1985)·2026

Related Experiment Video

Updated: Oct 5, 2025

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

17.5K

Manipulating CD4+ T Cell Pathways to Prevent Preeclampsia.

Eileen J Murray1, Serena B Gumusoglu1,2, Donna A Santillan1,3

  • 1Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, IA, United States.

Frontiers in Bioengineering and Biotechnology
|January 31, 2022
PubMed
Summary

Preeclampsia (PreE) is a pregnancy disorder causing hypertension and proteinuria. Immunomodulatory therapies targeting T cells show promise for preventing PreE by rebalancing the maternal inflammatory environment.

Keywords:
CD4+ T cellsearly pregnancypreeclampsiapreventiontreatment

More Related Videos

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
10:44

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function

Published on: June 2, 2019

6.0K
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

967

Related Experiment Videos

Last Updated: Oct 5, 2025

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

17.5K
A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
10:44

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function

Published on: June 2, 2019

6.0K
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

967

Area of Science:

  • Immunology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Preeclampsia (PreE) is a serious placental disorder marked by hypertension (HTN) and proteinuria, increasing risks for mother and child.
  • Current management for PreE is delivery, highlighting the need for preventative strategies.
  • An inflammatory CD4+ T cell imbalance is linked to inadequate spiral artery remodeling and oxidative stress in PreE.

Purpose of the Study:

  • To review the potential of immunomodulatory therapies for preventing preeclampsia (PreE).
  • To explore how targeting CD4+ T cell mechanisms can address PreE pathogenesis.

Main Methods:

  • Review of existing literature on immunomodulatory therapies investigated for immune-mediated inflammatory diseases.
  • Focus on therapies that modulate T cell responses, cytokines (e.g., TNF-α, IL-17, IL-6, IL-10, IFN-γ), and immune cell function.
  • Examination of specific therapeutic agents including monoclonal antibodies, statins, hormones, Treg therapy, and endothelin-1 inhibitors.

Main Results:

  • Immunomodulatory therapies can decrease pro-inflammatory factors like TNF-α, IL-17, and IL-6.
  • These therapies may stimulate regulatory T cells (Tregs) and reduce harmful immune cell activity.
  • Potential to improve spiral artery remodeling, placentation, and maternal tolerance of fetal antigens.

Conclusions:

  • Rebalancing the maternal inflammatory milieu via immunomodulation offers a promising avenue for PreE prevention.
  • Targeting CD4+ T cell pathways could mitigate oxidative stress and improve pregnancy outcomes in PreE.